European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
University of Liverpool Featured PhD Programmes
Catalysis Hub Featured PhD Programmes
University of Huddersfield Featured PhD Programmes
University College London Featured PhD Programmes
"colorectal" AND "cancer"…×
10 miles

colorectal cancer PhD Projects, Programs & Scholarships

We have 21 colorectal cancer PhD Projects, Programs & Scholarships

  • "colorectal" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 21
  Targeting steroid metabolism to block colorectal cancer proliferation
  Dr P Foster, Dr L Cox
Applications accepted all year round
Our group is a world leader in targeting specific aspects of steroid metabolism to block cancer growth. Our research has been instrumental in the successful pre-clinical and clinical development of various novel anti-cancer compounds.
  MRC Precision Medicine DTP: Trascriptome-wide association analysis of survival in colorectal cancer patients
  Prof M Dunlop, Dr E Theodoratou, Dr M Timofeeva
Application Deadline: 8 April 2019
Background. Colorectal cancer (CRC) is the second most common cause of cancer death in UK with 15,900 CRC deaths in 2014. The risk of recurrence and death depends very much on the stage of disease at the time of diagnosis with 5-year survival rate >90% for stage I and.
  Personalised surgery for colorectal cancer cure by use of fluorescence guidance- increasing safety & cancer precision
  Dr R Cahill
Applications accepted all year round
Surgery is the best treatment for colorectal cancer, most especially for cure. It remains a major operation with considerable risks meaning that every effort should be made to ensure maximum safety and effectiveness in obtaining a complete resection.
  Targeting BRAF mutant colorectal cancer using a combination of endoplasmic reticulum stress activators with inhibitors of the DNA repair pathways
  Research Group: Centre for Cancer Research and Cell Biology
  Dr S Van Schaeybroeck, Dr S McDade, Dr F Zenke
Application Deadline: 7 April 2019
Colorectal cancer (CRC) remains the 2nd most common cause of cancer death. BRAF mutated (MT) CRC occurs in 10% of CRC and these CRC patients do not respond efficiently to standard chemotherapeutic therapies and have the lowest overall outcome.
  Tumour microenvironment and colorectal cancer development: understanding the mechanisms of the tumour growth
  Prof D Kerr, Dr S Cai
Application Deadline: 26 July 2019
Our group has conducted a series of international adjuvant trials of chemotherapy for colorectal cancer (Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 – 1557).
  Exploration of 5-fluorouracil resistance mechanisms in colorectal cancer using 5-FU-resistant xenograft models
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Dr C Sutton
Applications accepted all year round
Despite therapeutic advances, colorectal cancer (CRC) still has a 45% mortality rate, and one of the major problems is the development of acquired resistance to treatment with anticancer drugs.
  Development of stimuli-responsive metallosupramolecular architectures for sensing and/or delivery of medicine for the treatment of solid tumours
  Research Group: Chemistry and Biosciences
  Dr D Petty, Dr M Najafzadeh, Dr S Pike
Applications accepted all year round
Applications are invited for a new self-funded PhD opportunity in the School of Chemistry & Biosciences at the University of Bradford.
  Do rural-dwellers experience cancer symptoms differently? A mixed methods PhD project using the USEFUL (a community-based cohort assessing prevalence and response to potential cancer symptoms)
  Prof P Murchie, Dr J Allan, Dr S Fielding
Application Deadline: 29 March 2019
1. Background to the project. Scottish people living further from key healthcare facilities have less chance of prompt cancer diagnosis and poorer cancer survival than those living closer-by[1].
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
Targeted therapy has had profound impact on outcomes for cancer patients.
  Cytochromes P450 in Cancer: Opportunities for Development of Personalised Medicine - Project 1
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Prof P Loadman
Applications accepted all year round
The improved understanding of cancer biology provides opportunities for the development of molecular targeted therapies.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.